Key Insights

Highlights

Success Rate

83% trial completion

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 52/100

Termination Rate

9.5%

2 terminated out of 21 trials

Success Rate

83.3%

-3.2% vs benchmark

Late-Stage Pipeline

19%

4 trials in Phase 3/4

Results Transparency

20%

2 of 10 completed with results

Key Signals

2 with results83% success

Data Visualizations

Phase Distribution

17Total
Not Applicable (6)
P 1 (3)
P 2 (4)
P 3 (4)

Trial Status

Completed10
Recruiting4
Unknown2
Terminated2
Withdrawn1
Active Not Recruiting1

Trial Success Rate

83.3%

Benchmark: 86.5%

Based on 10 completed trials

Clinical Trials (21)

Showing 20 of 20 trials
NCT06532539Phase 2Recruiting

Cadonilimab With Chemoradiation for Recurrent and Oligometastatic Endometrial Carcinoma

NCT07483658Not ApplicableNot Yet Recruiting

Non-inferiority Study Comparing Salvage Pelvic Radiotherapy in 25 Fractions (62.5 Gy/25) Versus 20 Fractions (52.5 Gy/20) for Recurrent Prostate Cancer After Surgery.

NCT03583619Not ApplicableCompleted

Randomized Trial of Accelerated Partial Breast Irradiation

NCT03583580Not ApplicableActive Not Recruiting

Accelerated Partial Breast Irradiation With IMRT in Early Breast Cancer

NCT06912087Phase 1Recruiting

Dose Finding Study of Zanzalintinib With Pembrolizumab and Cetuximab in Head and Neck SCC

NCT06942416Phase 2Recruiting

Iparomlimab and Tuvonralimab With Chemoradiation for the Treatment of Locally Recurrent and Oligometastatic Cervical Cancer

NCT01299987Not ApplicableCompleted

Prospective Phase II Study of Intraoperative Radiotherapy (IORT) in Elderly Patients with Small Breast Cancer

NCT06441110Phase 3Recruiting

Multicenter Clinical Trial on the Effectiveness and Safety of Instillation of BCG and Alternative BCG Protocols for Intermediate and High-risk Non-muscle Invasive Bladder Cancer

NCT05475301Completed

Incidence, Risk Factor, Treatment and Overall Survival of Locally Recurrent Rectal Cancer

NCT00100256Phase 1Unknown

Rhenium Re 188 P2045 in Patients With Lung Cancer Who Have Received or Refused to Receive Prior Chemotherapy

NCT05475288Completed

Incidence, Risk Factor, Treatment and Overall Survival of Locoregionally Recurrent Colon Cancer

NCT02801409Not ApplicableCompleted

Epidural Anesthesia-analgesia and Long-term Survival After Lung Cancer Surgery

NCT01594892Not ApplicableCompleted

Fractionated Radiosurgery for Painful Spinal Metastases

NCT01200992Phase 3Terminated

Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer

NCT01257152Completed

Screening MRI for Cancer Recurrence in Patients Treated With Breast Conserving Therapy

NCT00440310Phase 3Completed

Phase 3 Trial of Litx™ Plus Chemotherapy vs. Chemotherapy Only Treating Colorectal Cancer Patients With Recurrent Liver Metastases

NCT00949273Unknown

Safety and Efficacy Study of Cylindrical Abdominoperineal Resection to Treat Rectal Cancer

NCT00110526Phase 1Withdrawn

Gene Therapy for Prostate Cancer That Returns After Radiation Therapy

NCT00470340Phase 3Terminated

Chemotherapy or Not, Following Complete Treatment of Hepatic Cancer in Cirrhotic Patients

NCT00401323Phase 2Completed

Taxotere (Docetaxel) in 1st Line Treatment of Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

Scroll to load more

Research Network

Activity Timeline